Global Bioenergies Stock

Equities

ALGBE

FR0011052257

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris 11:35:00 2024-04-26 EDT 5-day change 1st Jan Change
1.788 EUR +2.17% Intraday chart for Global Bioenergies -2.83% -11.49%

Financials

Sales 2023 8.91M 9.53M 13.02M Sales 2024 * 1.75M 1.87M 2.56M Capitalization 32.35M 34.59M 47.28M
Net income 2023 -8M -8.55M -11.69M Net income 2024 * -8M -8.55M -11.69M EV / Sales 2023 4.1 x
Net cash position 2023 * 1.8M 1.92M 2.63M Net Debt 2024 * 5.35M 5.72M 7.82M EV / Sales 2024 * 21.5 x
P/E ratio 2023 *
-3.06 x
P/E ratio 2024 *
-2.84 x
Employees 45
Yield 2023 *
-
Yield 2024 *
-
Free-Float 83.85%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.17%
1 week-2.83%
Current month-2.93%
1 month-0.67%
3 months-7.36%
6 months-2.19%
Current year-11.49%
More quotes
1 week
1.75
Extreme 1.75
1.85
1 month
1.75
Extreme 1.75
2.13
Current year
1.75
Extreme 1.75
2.17
1 year
1.70
Extreme 1.702
4.37
3 years
1.70
Extreme 1.702
7.88
5 years
1.70
Extreme 1.702
9.94
10 years
1.70
Extreme 1.702
59.84
More quotes
Managers TitleAgeSince
Founder 53 08-10-05
Director of Finance/CFO - 13-12-31
Chief Tech/Sci/R&D Officer - 19-08-31
Members of the board TitleAgeSince
Director/Board Member 69 19-04-17
Founder 53 08-10-05
Director/Board Member 66 01-17
More insiders
Date Price Change Volume
24-04-26 1.788 +2.17% 15,539
24-04-25 1.75 -4.79% 22,241
24-04-24 1.838 +1.32% 27,453
24-04-23 1.814 -1.20% 15,869
24-04-22 1.836 -0.22% 14,368

Real-time Euronext Paris, April 26, 2024 at 11:35 am

More quotes
Global Bioenergies substitutes products of fossil origin with products of natural origin. In their quest for naturalness without compromising on performance, the cosmetics players are the Company's first customers. By 2027, Global Bioenergies will be operating its innovative process in a large-scale plant. By 2030, the Company plans to become a leader in the huge emerging market for sustainable aviation fuels, in order to fight against global warming.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.788 EUR
Average target price
2.6 EUR
Spread / Average Target
+45.41%
Consensus

Annual profits - Rate of surprise